Neither one is universally better. They do different jobs in different tissues, and almost every marine food that supplies one supplies the other alongside it.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the two long-chain omega-3 polyunsaturated fatty acids the body uses in meaningful amounts, and both come mainly from oily fish, shellfish and marine algae.
Both are built from a chain of carbon atoms with several double bonds along it. EPA has 20 carbons and 5 double bonds (20:5n-3). DHA has 22 carbons and 6 double bonds (22:6n-3). The "n-3" part means the first double bond sits three carbons from the tail end of the molecule, which is what makes a fat an omega-3 rather than an omega-6. Those extra kinks matter more than they sound. Each double bond puts a bend in the chain, so these molecules are loose and flexible compared with the straight, stiff saturated fats that also sit in your cell membranes.
There is a third omega-3 worth knowing about. ALA (alpha-linolenic acid) is the shorter, plant-based omega-3 found in flaxseed, chia, walnuts and some oils. The body can lengthen ALA into EPA and, through a longer sequence of steps, into DHA. That conversion exists but it is inefficient, and it is the reason plant omega-3 intake and marine omega-3 intake do not show up the same way in blood.
So when a label, a food or a lab report says "omega-3", it may mean any of the three. EPA and DHA are the two that end up embedded in your tissues in quantity, and they are the pair that an omega-3 blood test is built around.
DHA is longer and more flexible than EPA, so it has a bigger effect on the physical behaviour of cell membranes, while EPA is used more readily as a precursor for signalling molecules.
Think of a cell membrane as a crowded sheet of fat molecules with proteins floating in it. The shape of the fats in that sheet changes how fluid it is, how proteins sit inside it, and how clusters of signalling proteins organise themselves. Research suggests that EPA and DHA have distinct effects on cell function, with DHA exerting the greater influence on membrane structure and organisation 1. That single structural difference cascades into most of the other contrasts between them.
EPA, meanwhile, is a close structural cousin of arachidonic acid, the omega-6 fat that the body converts into many of its pro-inflammatory signalling molecules. Because EPA competes for the same enzymes, it feeds into those pathways and shifts the mix of molecules produced.
| Feature | EPA | DHA |
|---|---|---|
| Full name | Eicosapentaenoic acid (20:5n-3) | Docosahexaenoic acid (22:6n-3) |
| Size | 20 carbons, 5 double bonds | 22 carbons, 6 double bonds |
| Main role | Precursor for signalling molecules | Structural component of membranes |
| Where it concentrates | Spread across tissues at relatively low levels | Brain grey matter, retina, sperm, nerve membranes |
| Food sources | Oily fish, shellfish, some algae oils | Oily fish, shellfish, algae oils, DHA-enriched eggs |
| On a lab report | Reported inside the combined index, or separately on a full fatty acid profile | Reported inside the combined index, or separately on a full fatty acid profile |
DHA concentrates heavily in a few specialised tissues, while EPA is spread more thinly across the body.
The brain is the clearest example. DHA makes up a large share of the long-chain polyunsaturated fat in grey matter phospholipids, and it is also a dominant fatty acid in the photoreceptor membranes of the retina and in sperm cell membranes. These are all tissues that depend on membranes bending, flexing and changing shape quickly. EPA is present in the brain too, but at far lower concentrations, because it is turned over rapidly once it arrives rather than stored in place.
Outside those tissues, the picture evens out. Red blood cells, platelets, heart muscle, liver and fat tissue all carry both fatty acids in their membranes, with the proportions reflecting what you have been eating over the preceding weeks and months.
This distribution is the single most useful thing to hold on to. DHA is largely a building material that stays where it is put. EPA behaves more like a circulating resource that gets drawn on. It also explains why the brain and eye discussion tends to centre on DHA, while the blood lipid and inflammation discussion involves both, with EPA getting more of the attention.
They change different parts of the same system, DHA mostly by altering the membrane itself, EPA mostly by changing which signalling molecules get made.
When DHA is incorporated into a membrane, it increases fluidity and disrupts the tightly packed cholesterol-rich microdomains that many receptors cluster inside. That changes how receptors group together and how signals pass through. Research suggests that DHA and EPA differ in how they alter membrane order and in their downstream effects on cell signalling, with DHA being the more potent of the two for membrane-level changes 1.
Both fatty acids also displace arachidonic acid from membrane phospholipids. When a cell is activated, the enzymes that would normally release arachidonic acid and turn it into inflammatory signalling molecules find omega-3 substrate instead, producing a different family of mediators. Both EPA and DHA also serve as the starting material for specialised pro-resolving mediators, the molecules involved in switching inflammation off rather than simply damping it down.
The practical takeaway is that the two are not redundant. A tissue that needs structural DHA cannot substitute EPA for it, and a signalling pathway that draws on EPA does not get the same input from DHA. This is why most dietary sources and most of the guidance around them deal with EPA and DHA together rather than treating them as rival ingredients.
Both lower triglycerides, and head-to-head comparisons have generally found DHA to be at least as effective as EPA on this marker.
Triglycerides are the fats packaged into lipoproteins and carried through the bloodstream, and they are one of the few markers where marine omega-3 intake produces a consistent, measurable change. In people with elevated triglycerides specifically, research suggests that both fatty acids lower triglyceride levels while differing in their effects on other lipoprotein measures 4.
Mechanistically, the effect comes from the liver. Omega-3 fats reduce the assembly and secretion of triglyceride-rich particles and increase the rate at which fatty acids are burned rather than packaged for export.
What this does not mean is that a triglyceride result is a reason to act alone. A raised triglyceride value can reflect many things, including recent meals, alcohol intake, body composition, thyroid function and blood sugar control, and a single number interpreted in isolation tells you very little. If your triglycerides sit outside the standard reference range, that is worth discussing with a clinician alongside the rest of your lipid panel rather than treating as a standalone verdict.
No, and this is the clearest practical difference between them on a lipid panel.
Studies indicate that DHA raises both HDL cholesterol and LDL cholesterol more than EPA does, while the two are broadly comparable in their triglyceride-lowering effect 3. The same pattern appears in reviews of the two fatty acids in people with elevated triglycerides, where DHA is associated with a greater rise in LDL cholesterol than EPA 4. Research suggests the two also differ across a wider set of cardiovascular risk factors, including lipoprotein particle size and composition, rather than differing on one measure alone 2.
A rise in LDL cholesterol sounds straightforwardly unwelcome, but the detail matters. Part of what happens when triglycerides fall is that lipoprotein particles are remodelled, and small dense particles shift towards larger, more buoyant ones. A measured LDL cholesterol value can move upward as a result of that remodelling without the number of circulating particles changing in the same direction, which is one reason ApoB is increasingly looked at next to LDL cholesterol.
This is exactly the kind of result that is easy to misread on your own. The useful next step is not to draw a conclusion from one value but to look at the full lipid picture over time with a clinician who can see your history.
Both fatty acids have been examined for effects on blood pressure and on circulating inflammatory markers, and the measured effects are modest rather than dramatic.
Research suggests that EPA and DHA intake is associated with reductions in blood pressure and with changes in inflammatory markers, with the size of the effect varying between the two fatty acids and across the markers assessed 5. DHA has also been examined for effects on blood pressure and heart rate relative to EPA, and research suggests the two differ in this respect as well as on blood lipids 2.
The inflammation side is where overclaiming is easiest. Markers such as hs-CRP, IL-6 and TNF-alpha are indirect readouts of a complex system, and a change in one of them is a signal, not an outcome. Omega-3 fats plausibly influence these markers through the eicosanoid and pro-resolving mediator pathways described earlier, but a shift in a marker is best read as a direction of travel.
If you track hs-CRP, it is worth remembering that it rises sharply with any recent infection, injury or intense training session. A single elevated reading usually warrants a repeat test before anyone reads anything into it, and that call belongs with your clinician.
There is no settled answer, and direct comparisons have not established one fatty acid as clearly superior for vascular risk prevention.
A review comparing the two specifically as options for vascular risk prevention concluded that the case for choosing one over the other is not clear-cut, with differences in lipid effects that do not translate neatly into a single recommendation 6. Research suggests the two differ across individual cardiovascular risk factors in ways that partly offset each other, DHA having the larger effect on some measures and EPA on others 2.
Separately, blood levels themselves carry information. Research suggests that higher blood levels of EPA plus DHA are associated with lower cardiovascular risk in population data, which is why the proportion of these fats in red cell membranes has been proposed as a risk marker in its own right 7.
For most people reading this, the practical conclusion is unglamorous. Rather than picking a side, it is more useful to know your own level, see how it sits against typical and optimal ranges, and discuss with a clinician whether anything about your intake or wider risk picture is worth changing. Any decision about a prescription therapy is one a licensed provider evaluates after reviewing you.
Partly, and the traffic runs more easily in one direction than the other.
The body builds EPA and DHA from ALA through a sequence of enzyme steps that add length and double bonds. ALA becomes EPA, EPA becomes DPA, and DPA eventually becomes DHA through a longer route. The enzymes involved are shared with the omega-6 pathway, so a diet heavy in omega-6 fats competes for the same machinery. The overall conversion rate to EPA is low, and the rate to DHA is lower still, which is why relying on plant sources alone tends to move DHA levels less than people expect.
Going the other way, some DHA is converted back to EPA within the body. In practice this means a DHA-rich source tends to lift both EPA and DHA levels, while an EPA-rich source raises EPA more reliably than it raises DHA.
Genetics plays a part here too. Common variations in the genes coding for the desaturase enzymes shift how efficiently a person converts ALA onward, which is part of why two people eating similar diets can land on quite different blood levels. That individual variability is the main argument for measuring rather than assuming, since intake and blood level are only loosely related at the level of one person.
Oily fish and marine algae are the practical sources of both, with algae being the original producer at the bottom of the food chain.
Fish do not manufacture EPA and DHA themselves in any quantity. They accumulate them by eating algae and smaller organisms that do. The fish most often named as rich sources are salmon, sardines, mackerel, herring, anchovies and trout, and roe and shellfish contribute as well. The ratio of EPA to DHA varies between species and between wild and farmed fish, since it tracks what the animal was eating.
Algae oils are the direct route and are the main option for people who avoid fish. Most supply DHA prominently, and some supply EPA alongside it. DHA-enriched eggs exist where hens have been fed an omega-3 source.
ALA-rich plant foods such as flaxseed, chia, hemp and walnuts are genuine omega-3 sources, but as covered above they feed into EPA and DHA only through an inefficient conversion.
Cooking method makes a small difference. Long, high-heat frying degrades more of these fragile fats than gentle cooking does, and oil used for frying may carry some away with it.
This page does not recommend amounts, products or schedules. Dietary targets and whether a supplement is appropriate for you are decisions to make with a clinician or a registered nutrition professional who knows your history.
It is a single blood test reporting EPA plus DHA combined, expressed as a percentage of the total fatty acids in red blood cell membranes. Research suggests red cell levels reflect longer-term intake rather than the last meal, because those membranes turn over slowly 7.
Typical lab reference ranges run from 6 to 12 %, and reference ranges vary by lab, age and sex. FitScript's optimal range for this marker is 8 to 12 %. Optimal ranges are optimization targets rather than diagnostic cut-offs.
For how the result is interpreted, what the ranges mean in detail and what a high or low value may reflect, the dedicated Omega-3 Index page covers it properly.
Only if you order a test that reports them separately, because the standard index combines them into one number.
The combined figure is deliberate. It was designed as a single, reproducible number that reflects overall marine omega-3 status, and combining the two avoids the noise that comes from fluctuations in either one alone. For most people wanting a status check, that one number answers the question.
A full red cell fatty acid profile is the alternative. It breaks out EPA, DHA, DPA, arachidonic acid, the main omega-6 fats, saturated fats and trans fats individually, and it usually reports derived ratios such as the omega-6 to omega-3 ratio and the arachidonic acid to EPA ratio. That level of detail is useful when someone wants to see how their intake is actually landing, for example where an algae-based source is supplying mostly DHA, or where a very high omega-6 intake is competing for the same enzymes.
One caution on ratios. Because they are a fraction, a ratio can move because the numerator changed, because the denominator changed, or because both shifted slightly. Reading the individual values underneath the ratio avoids drawing the wrong conclusion from a number that moved for an unexpected reason.
Intake of marine omega-3 is the largest single influence, but several other factors shape where a given intake lands.
The main ones worth knowing about:
Because these factors stack, two people with similar diets can return very different results. That is the honest argument for testing rather than estimating from a food diary.
The markers that sit nearest to this one are the lipid panel, a marker of inflammation and the measures of metabolic health that interact with them.
A standard lipid panel including triglycerides, total cholesterol, HDL and LDL is the obvious companion, since triglycerides are the marker most responsive to marine omega-3 intake. ApoB adds the particle count that LDL cholesterol alone does not capture, which is useful given the lipoprotein remodelling described earlier. An hs-CRP gives a general inflammation reading, though it needs interpreting against recent illness and training load.
Beyond those, fasting glucose, insulin and HbA1c matter because triglyceride levels and insulin resistance move together, and liver markers are worth seeing because the liver is where triglyceride-rich particles are assembled. A full red cell fatty acid profile adds the omega-6 side of the ledger.
This is the logic behind a broad panel rather than a single test. FitScript's membership covers 150+ biomarkers tested per year, with results interpreted by Atlas, FitScript's AI health advisor, so a marker like this one is read next to the lipid, metabolic and inflammatory markers it interacts with rather than on its own.
Observation first. A result below the typical reference range tells you that the proportion of these fats in your red cell membranes is lower than the lab's expected spread. What it may reflect is a diet low in oily fish and marine sources, poor conversion from plant omega-3, higher body mass distributing intake more thinly, or reduced fat absorption. What it does not tell you is whether anything is wrong, because a single marker never carries that weight.
High results are far less common and usually mean a steady, substantial marine intake. Because the index is a percentage of total fatty acids, it is bounded, and values at the upper end are not generally read as a problem in themselves. That said, people with bleeding concerns, or anyone with surgery coming up, should raise their omega-3 intake and any supplements with their clinician in advance.
The next step with either result is the same. Bring it to a clinician together with your lipid panel and your history, look at the trend across repeat tests rather than one snapshot, and let someone who can see the whole picture decide whether a change is warranted. Where a prescription therapy is under consideration, a licensed provider evaluates whether it is appropriate for you.
Any result outside the standard reference range deserves a conversation, and some situations warrant one promptly.
Bring it up without waiting if your triglycerides are markedly outside the standard range, if you have a personal or family history of early cardiovascular disease, if you are pregnant or planning a pregnancy, if you have a bleeding disorder or surgery scheduled, or if you are managing an existing condition where any change in diet or supplementation should be reviewed first. In people with chronic liver, kidney or digestive conditions, fat absorption and lipid handling can both be affected, which changes how a result should be read.
It is also worth a conversation in the quieter case, where you simply want to know whether your intake is landing where you think it is. Testing answers that question, and a clinician can tell you whether the answer changes anything for you specifically.
This article is educational and is not medical advice. Discuss your own results and any treatment or supplement decision with a clinician or licensed provider who can review your full history.
If you want to know what testing this involves and what it costs before deciding, the omega-3 index test cost page sets out what the test measures and what goes into its price.
Neither is better in every situation. DHA is the structural one, concentrated in brain, retina and nerve membranes, while EPA acts more as a precursor for signalling molecules. Most marine foods supply both together, and whether one deserves more emphasis for you is a question for a clinician who knows your history and your lab results.
Both have roles the other cannot fully cover. A tissue that needs DHA for its membrane structure cannot substitute EPA for it. In practice this rarely requires a decision, because oily fish, shellfish and most algae oils supply both at the same time.
No. It reports EPA plus DHA combined as a single percentage of the fatty acids in your red blood cell membranes. If you want the two broken out individually, along with the omega-6 fats and the common ratios, you need a full red cell fatty acid profile rather than the index alone.
Yes. Algae oils supply DHA and, depending on the product, EPA as well, and algae are the original source that fish accumulate these fats from. Plant foods such as flaxseed, chia and walnuts supply ALA, the shorter omega-3, which the body converts into EPA and DHA only inefficiently.
Typical lab reference ranges run from 6 to 12 %, and ranges vary by lab, age and sex. FitScript's optimal range for the Omega-3 Index is 8 to 12 %, which is an optimization target rather than a diagnostic cut-off. Your clinician interprets your number against your wider panel and history.
Slowly. The test looks at red blood cell membranes, which turn over over a period of months rather than days, so the result reflects your longer-term pattern instead of your last meal. That is useful for tracking a real change, but it means a retest too soon after a change will not show much.
Some loss happens with long, high-heat cooking such as deep frying, and oil used for frying can carry some of the fat away. Gentler methods such as baking, steaming or poaching preserve more. Tinned oily fish packed in its own oil retains the fats as well.
The index is a percentage, so it is bounded, and high values usually just reflect a steady marine intake rather than a problem. Even so, anyone with a bleeding disorder, or with surgery or a procedure scheduled, should tell their clinician about their omega-3 intake and any supplements well in advance.